Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)
April 11, 2022
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH) Initial Cases Have Now Been...
Read MoreTeleflex Receives Reimbursement Approval for the UroLift® System in Japan
December 13, 2021
Will expand patient access to breakthrough BPH treatment
Read MoreThe UroLift® System Receives Bronze Award for Best New Branded Television Campaign and Honorable Mention in the Best Branded Website Category from DTC Perspectives
November 2, 2021
WAYNE, Pa.--October 29, 2021--Teleflex Incorporated (NYSE: TFX) announced today that the UroLift® System was honored by DTC Perspectives with a...
Read MoreTeleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarged Prostate Procedures at the American Urological Association 2021 Annual Meeting
September 14, 2021
Late-Breaking Data Presentation Reveals How UroLift PUL’s Post-Operative Events Compare With Other Minimally Invasive Procedures and Traditional...
Read MoreTeleflex Unveils the UroLift Advanced Tissue Control (ATC)® System and the UroLift® 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting
September 9, 2021
New real-world data findings along with new product evolutions demonstrate why the UroLift® System is the right solution for most BPH patients WAYNE,...
Read MoreNew Study Provides Insights into the Biocompatibility and Durability of the UroLift® System in Improving Benign Prostatic Hyperplasia Symptoms
August 30, 2021
WAYNE, Pa., August 20, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of clinical data for the UroLift®...
Read MoreLargest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift System
July 9, 2021
Real-World Claims Data Presented at Annual European Association of Urology Congress Reveal Overall Complication Rates are Lowest after Treatment with...
Read MoreTeleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology Congress
July 6, 2021
Presentations to Provide New Insights on the Real-World Effectiveness and Durability of Leading Minimally Invasive Procedure for Enlarged Prostate
Read MoreNew Data Suggest Men with Urinary Symptoms Often Anticipate Bathroom Needs and Avoid Events and Activities They Enjoy
June 16, 2021
Teleflex survey finds “extreme bathroom planning” to accommodate urinary symptoms common with an enlarged prostate (BPH) impacts daily activities
Read MoreTeleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System
March 9, 2021
WAYNE, Pa., March 9, 2021 (GLOBE NEWSWIRE) – Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated...
Read More
